null

SMILES CC1(N)CCN(CC1)c1cnc(cn1)-c1cccc(Cl)c1Cl

InChI Key InChIKey=BXUXQYJVGIQZPP-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 38021   

TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMpH: 7.2 T: 2°CAssay Description:More specifically, the phosphatase reactions were performed at room temperature in 384-well black polystyrene plate, flat bottom, low flange, non-bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q25X2C0SUS Patent
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2N87D37US Patent
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BR8VJVUS Patent
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:More specifically, the phosphatase reactions were performed at room temperature in 384-well black polystyrene plate, flat bottom, low flange, non-bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5ZMGUS Patent
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of human 6his-tagged SHP2 (2 to 593 residues) expressed in Escherichia coli BL21 Star (DE3) cells preincubated with IRS1_pY1172(dPEG8)pY12...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JQ14J1PubMed
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:Allosteric inhibition of 6x-histidine tagged human SHP2 (Met1-L525 residues) expressed in Escherichia coli BL21 Star (DE3) using IRS1_pY1172(dPEG8)pY...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CC14BBPubMed
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Novartis AG

US Patent
LigandPNGBDBM38021(US10093646, Compound 2 | US10301278, Example 00004...)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation st...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WW7MS2US Patent